Evidence map›Paper›PMID 16493151›Full record

ReviewProceedings of the American Thoracic Society2006

Pulmonary vasculitis.

Kevin K Brown

Abstract readReview
In one paragraph

Review in Proceedings of the American Thoracic Society, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Granulomatosis with polyangiitis presenting as isolated ear involvement: a case series and literature review.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Can You Establish the Cause of This Patient's Shortness of Breath?Journal of the advanced practitioner in oncology · 2023
    Article
  10. Article
  11. Pulmonary renal syndrome: a clinical review.Breathe (Sheffield, England) · 2022
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Genetics of COPA syndrome.The application of clinical genetics · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Kevin K BrownPulmonary Division, Department of Medicine, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206, USA. brownk@njc.org

Funding

SCOR: Pathobiology of Fibrotic Lung DiseaseP50HL067671 · NHLBI · NATIONAL JEWISH HEALTH · PI MASON, ROBERT JAMES · 2002 to 2005
$7.2M
SCOR: Pathobiology of Fibrotic Lung DiseaseP01HL067671 · NHLBI · NATIONAL JEWISH HEALTH · PI HENSON, PETER M · 2001 to 2001
$1.7M
NHLBI NIH HHS HL67671
6 · The paper itself

Abstract

Pulmonary vasculitis describes a number of distinct disorders that are pathologically characterized by the destruction of blood vessels. The clinical manifestations of each disorder are defined by the size, type, and location of the affected vasculature. The clinical approach to these disorders rests upon an astute clinician considering the diagnosis and identifying the specific patterns of clinical, radiologic, laboratory, and pathologic abnormalities. Lung involvement is most commonly seen with the primary, idiopathic, small-vessel, or antineutrophil cytoplasmic antibody-associated vasculitides; Wegener's granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome. However, primary, idiopathic medium and large-vessel vasculitis, primary immune complex-mediated vasculitis, and secondary vasculitis are all capable of presenting with lung involvement. In this article, we focus on the more common, antineutrophil cytoplasmic antibody-associated disorder, vasculitides.

Indexed as

Antibodies, Antineutrophil CytoplasmicBiopsyBronchoscopyDiagnosis, DifferentialHumansLung DiseasesRadiography, ThoracicVasculitisAntibodies, Antineutrophil Cytoplasmic

Identifiers

PMID16493151
PMCPMC2658676

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.